Anzeige
Meldung des Tages: Das ist kein Gold-Boom, das ist ein Systembruch – und er hat gerade erst begonnen

OSR Aktie News

Aktie
WKN:  A411DT ISIN:  US68840D1028 US-Symbol:  OSRH Branche:  Biotechnologie Land:  USA
0,541 $
-0,0126 $
-2,28%
0,46072 € 21:09:45 Uhr
Depot/Watchlist
Marktkapitalisierung *
10,51 Mio. €
Streubesitz
52,35%
KGV
-
Index-Zuordnung
-

OSR News

02.12.25 - PR Newswire
Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three Months
Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three Months PR Newswire
01.12.25 - PR Newswire
OSR Holdings to Present at the Emerging Growth Conference on December 10, 2025
OSR Holdings to Present at the Emerging Growth Conference on December 10, 2025 PR Newswire
21.11.25 - PR Newswire
Vaximm AG, an OSR Company, Enters Term Sheet With BCM Europe for Potential VXM01 License with $20M Upfront and Up to $815M in Milestones
Vaximm AG, an OSR Company, Enters Term Sheet With BCM Europe for Potential VXM01 License with $20M Upfront and Up to $815M in Milestones PR Newswire
14.11.25 - PR Newswire
OSR Holdings Appoints Scientific Co-Founder Dr. Andreas Niethammer as Chief Executive Officer of Vaximm AG to Lead Next Phase of Immuno-Oncology Expansion
OSR Holdings Appoints Scientific Co-​Founder Dr. Andreas Niethammer as Chief Executive Officer of Vaximm AG to Lead Next Phase of Immuno-​Oncology Expansion PR Newswire
06.11.25 - PR Newswire
OSR Holdings Announces Woori IO's Noninvasive Glucose Monitor Demonstrates High Accuracy and Precision in Company-Sponsored Pilot Study
OSR Holdings Announces Woori IO's Noninvasive Glucose Monitor Demonstrates High Accuracy and Precision in Company-​Sponsored Pilot Study PR Newswire
14.10.25 - PR Newswire
OSR Holdings Signs Definitive Agreement to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring with Potential to Transform Diabetes Care
OSR Holdings Signs Definitive Agreement to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring with Potential to Transform Diabetes Care PR Newswire
09.09.25 - PR Newswire
OSR Holdings Receives Nasdaq Minimum Bid Price Deficiency Notice; Company Highlights Unusual Trading Activity
OSR Holdings Receives Nasdaq Minimum Bid Price Deficiency Notice; Company Highlights Unusual Trading Activity PR Newswire
01.08.25 - PR Newswire
OSR Holdings to Host Virtual Investor Event Providing Key Corporate Updates and Strategic Direction on August 6, 2025
OSR Holdings to Host Virtual Investor Event Providing Key Corporate Updates and Strategic Direction on August 6, 2025 PR Newswire
31.07.25 - PR Newswire
OSR Holdings Provides Transparency Update on Equity Financing Instruments
OSR Holdings Provides Transparency Update on Equity Financing Instruments PR Newswire
30.07.25 - PR Newswire
OSR Holdings Provides Strategic Update on Woori IO Term Sheet and Share Exchange Structure
OSR Holdings Provides Strategic Update on Woori IO Term Sheet and Share Exchange Structure PR Newswire
24.07.25 - PR Newswire
OSR Holdings Enters into Term Sheet to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring Technology
OSR Holdings Enters into Term Sheet to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring Technology PR Newswire
15.07.25 - PR Newswire
OSR Holdings Appoints Dr. Andreas Niethammer as Chief Medical Officer of Vaximm AG, an OSR Company
OSR Holdings Appoints Dr. Andreas Niethammer as Chief Medical Officer of Vaximm AG, an OSR Company PR Newswire
09.07.25 - PR Newswire
OSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe AG
OSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe AG PR Newswire
09.07.25 - PR Newswire
OSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe AG
OSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe AG PR Newswire
08.07.25 - PR Newswire
OSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe AG
OSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe AG PR Newswire
22.05.25 - PR Newswire
OSR Holdings, BCM Europe, and Taekwondo Cooperative Announce Strategic MOU to Launch Blockchain-Based OSRH Token
OSR Holdings, BCM Europe, and Taekwondo Cooperative Announce Strategic MOU to Launch Blockchain-​Based OSRH Token PR Newswire
02.05.25 - PR Newswire
Darnatein to Present at 14th International BMP Conference Highlighting Advances in Regenerative Biologics
Darnatein to Present at 14th International BMP Conference Highlighting Advances in Regenerative Biologics PR Newswire
09.04.25 - PR Newswire
Darnatein, an OSR Company, Broadens Intellectual Property Protection for Innovative Osteoarthritis Treatment Technology
Darnatein, an OSR Company, Broadens Intellectual Property Protection for Innovative Osteoarthritis Treatment Technology PR Newswire
03.04.25 - PR Newswire
OSR Holdings, Inc. (NASDAQ: OSRH) Enters Into $80 Million Common Stock Purchase Agreement With White Lion GBM Innovation Fund, With An Eye Towards Leveraging Innovate GBM's Non-Profit Ecosystem to Accelerate Glioblastoma Therapies
OSR Holdings, Inc. (NASDAQ: OSRH) Enters Into $80 Million Common Stock Purchase Agreement With White Lion GBM Innovation Fund, With An Eye Towards Leveraging Innovate ...
26.03.25 - PR Newswire
Vaximm AG, an OSR Company, Announces Results from Phase 2a Trial of VXM01 and Avelumab Combination Therapy in Glioblastoma
Vaximm AG, an OSR Company, Announces Results from Phase 2a Trial of VXM01 and Avelumab Combination Therapy in Glioblastoma PR Newswire

Newssuche

Videos

newspaper
16.12.25 -8,75%
Technical Trading: DAX Setup mit Kurzfrist Trade
DAX Long Typ: Turbo Open End WKN: VK2CGA Hebel:11,30 Laufzeit: OpenEnd Einstieg: Market ... Mehr »